(PRESS RELEASE) BELLEVUE, WA — The U.S. Patent and Trademark Office has issued a notice of allowance to complement the 12 patents already issued to Innovega Inc., a company whose stated goal is “to deliver stylish, lightweight, wearable display technology with high resolution and a panoramic field of view.”
The recently allowed patent, titled “Contact Lens and Method and Systems for Constructing a Contact Lens,” claims the ability to supply the required oxygen to the cornea when the lens contains components that are not oxygen permeable.
“Our team continues to advance our intellectual property, refine our display eyewear reference designs, sponsor clinical testing and conduct discussions about our technology with potential contact lens and display eyewear partners,” said Steve Willey, Innovega co-founder, president and CEO.
Innovega is currently conducting a round of financing with New York-based SeedInvest for the purpose of completing its Phase III FDA clinical investigations for the iOptik and eMacula contact lenses.
The family of Innovega patents claim systems and methods for coupling eyeborne optics with display eyewear in pursuit of two goals: eliminating the need to wear a heavy, cumbersome apparatus; and delivering a panoramic field of view instead of the narrow field that’s inherent with conventional waveguide optics. Innovega’s latest patent allowance adds to one allowed in mid-2018 that claimed methods for regulating water vapor transmissibility while maintaining oxygen transmissibility in ultra-high oxygen permeable lens materials.
Both patents were filed by inventors and scientists Jerome Legerton, William Meyers and Jay Marsh.